Alexander A. Fitzpatrick
Insider Reports History
- Location
- San Diego, CA
- Signature
- /s/ Kathleen Scott, Attorney-in-Fact
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Alexander A. Fitzpatrick:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ARS Pharmaceuticals, Inc. | Chief Legal Officer | Common Stock | 89,613 | $1,263,238 | $14.10 | 20 May 2025 | Direct |
| Evofem Biosciences, Inc. | General Counsel and Secretary | Common Stock | 516,422 | $19,882 | $0.0385 | 18 Feb 2022 | Direct |
| Evofem Biosciences, Inc. | General Counsel and Secretary | Stock option (right to buy) | 300,000 | 18 Feb 2022 | Direct | ||
| ARS Pharmaceuticals, Inc. | Chief Legal Officer | Stock option (right to buy) | 240,000 | 02 Jan 2026 | Direct |
Insider Reports Filed by Alexander A. Fitzpatrick
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SPRY | ARS Pharmaceuticals, Inc. | 02 Jan 2026 | 1 | $0 | 4 | Chief Legal Officer | 05 Jan 2026, 16:25 |
| SPRY | ARS Pharmaceuticals, Inc. | 20 May 2025 | 3 | -$893,513 | 4 | Chief Legal Officer | 22 May 2025, 17:00 |
| SPRY | ARS Pharmaceuticals, Inc. | 02 Jan 2025 | 1 | $0 | 4 | Chief Legal Officer | 03 Jan 2025, 16:30 |
| SPRY | ARS Pharmaceuticals, Inc. | 02 Jan 2024 | 1 | $0 | 4 | Chief Legal Officer | 04 Jan 2024, 16:38 |
| SPRY | ARS Pharmaceuticals, Inc. | 28 Sep 2023 | 2 | +$319,954 | 4 | Chief Legal Officer | 02 Oct 2023, 16:23 |
| SPRY | ARS Pharmaceuticals, Inc. | 03 Jan 2023 | 1 | $0 | 4 | Chief Legal Officer | 05 Jan 2023, 16:00 |
| SPRY | ARS Pharmaceuticals, Inc. | 01 Dec 2022 | 0 | $0 | 3 | Chief Legal Officer | 01 Dec 2022, 20:11 |
| EVFM | Evofem Biosciences, Inc. | 18 Feb 2022 | 2 | $0 | 4 | General Counsel and Secretary | 23 Feb 2022, 15:08 |
| EVFM | Evofem Biosciences, Inc. | 31 Dec 2021 | 1 | $0 | 4 | General Counsel and Secretary | 04 Jan 2022, 15:06 |
| EVFM | Evofem Biosciences, Inc. | 20 Dec 2021 | 1 | +$9,725 | 4 | General Counsel and Secretary | 20 Dec 2021, 15:20 |
| EVFM | Evofem Biosciences, Inc. | 10 Jun 2021 | 1 | +$10,250 | 4 | General Counsel and Secretary | 10 Jun 2021, 19:29 |
| EVFM | Evofem Biosciences, Inc. | 20 May 2021 | 1 | -$36,223 | 4 | General Counsel and Secretary | 21 May 2021, 16:26 |